2022 Annual Meeting | P1 - Poster Session 1

Date Saturday 04/02/22

Time 08:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Sleep, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Neuromuscular and Clinical Neurophysiology (EMG), Pain

CME Available 0.00 CME credit

Program Materials Program Evaluations

Event Timeline
08:00 AM - 09:00 AM PDT	Abstract	9-001 - Anti-GABAA receptor encephalitis in patients with multiple myeloma after autologous stem cell transplant: A report of 3 cases Yoji Hoshina, MD
08:00 AM - 09:00 AM PDT	Abstract	9-002 - A Case of FIRES/NORSE Associated with a Pathogenic Heterozygous Variant in TNFRSF13B Implicated in Common Variable Immunodeficiency Jacqueline Shanley, CRC
08:00 AM - 09:00 AM PDT	Abstract	9-003 - Cyclophosphamide in Autoimmune GFAP Astrocytopathy Mohona Reza, MD
08:00 AM - 09:00 AM PDT	Abstract	9-004 - Paraneoplastic Cerebellar Degeneration – Uncommon Presentations, Unclassified Autoantibodies Susmit Tripathi, MD
08:00 AM - 09:00 AM PDT	Abstract	9-005 - Seizure Control and Cognitive Outcomes in Patients with Encephalitis - A Retrospective Review Omer W. Naveed, MD
08:00 AM - 09:00 AM PDT	Abstract	9-006 - Neuroimaging Findings In Case Series Of 8 Patients With Autoimmune Encephalitis In A Single Academic Center Hongxuyang Yu, MD
08:00 AM - 09:00 AM PDT	Abstract	9-007 - A Pathway for Evaluation and Management of Anti-NMDA Receptor Encephalitis During Pregnancy Diana Ontiveros, MD
08:00 AM - 09:00 AM PDT	Abstract	15-001 - Atogepant 60 mg Once-Daily Shows Efficacy for the Preventive Treatment of Migraine: Results From a 52-Week Open-Label Extension Trial Brett Dabruzzo, PharmD
08:00 AM - 09:00 AM PDT	Abstract	15-002 - Decrease in Body Weight With Once-Daily Atogepant for the Preventive Treatment of Migraine: A Post Hoc Analysis Jessica Ailani, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	15-003 - Evaluation of Headache Profiles in Pediatric Patients Pre and Post Participation in Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody (Anti-CGRP mAb) Studies
08:00 AM - 09:00 AM PDT	Abstract	15-004 - Safety and Efficacy of Fremanezumab in Different Racial and Ethnic Subgroups of Patients With Migraine: A Pooled Analysis of Phase 3 Studies Amarylis Velez-Perez
08:00 AM - 09:00 AM PDT	Abstract	15-005 - A Case Report of 58-year-old Man with CADASIL Leading to Acute Ischemic Stroke and Intracerebral Hemorrhage Consecutively. Dong Jin Shin, MD
08:00 AM - 09:00 AM PDT	Abstract	3-001 - Association of Diastolic Dysfunction and Cognitive Impairment in the Framingham Heart Study Alicia S. Parker, MD
08:00 AM - 09:00 AM PDT	Abstract	3-002 - Air Pollution and Dementia: A Systematic Review and Meta-Analysis Elissa Wilker, Other
08:00 AM - 09:00 AM PDT	Abstract	3-003 - Two novel brain iron networks explain aging-related variation in deep gray matter Jack Reeves
08:00 AM - 09:00 AM PDT	Abstract	3-004 - Offspring Sex and Parental Cognition in Mid-life and Older Adulthood Katrin Wolfova, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	12-001 - NYX-2925, a novel N-methyl-D-aspartate Receptor Positive Allosteric-Modulator, showed antinociceptive Activity in functional Neuroimaging evaluations correlated with improved Patient reported Pain and Fibromyalgia Symptoms Harald Murck, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	12-002 - Clinical Milestones in PSP and MSA as Triggers for Palliative Care Intervention Robin Bessemer, MD
08:00 AM - 09:00 AM PDT	Abstract	12-003 - Out of Sight and Out of Mind: The Nocebo Effect; An Unmet Educational Need in Academic Medical Centers Derek J. Notch, MD
08:00 AM - 09:00 AM PDT	Abstract	12-004 - Racial Differences In Palliative Care Utilization And Impact On Inpatient Mortality Length Stay And Costs Among Patients With Intracerebral Hemorrhage
08:00 AM - 09:00 AM PDT	Abstract	12-005 - Implementing a Neuropalliative Care Curriculum for Neurology Residents Sonya T. Gleicher, MD
08:00 AM - 09:00 AM PDT	Abstract	12-006 - Implementing Team-Based Outpatient Palliative Care in Parkinson’s Foundation Centers of Excellence (COE): Study Design Megan Dini, MA
08:00 AM - 09:00 AM PDT	Abstract	12-007 - Fluoroscopy Guided Block in Nervus Intermedius Neuralgia MerryJean Losso, MD
08:00 AM - 09:00 AM PDT	Abstract	12-008 - Timing and Utilization of Inpatient Palliative Care Consultation in People with High-Grade Glioma Caroline Crooms, MD, MPH
08:00 AM - 09:00 AM PDT	Abstract	12-009 - Stressors Experienced by Primary Caregivers of Severe Acute Brain Injury Patients Recovering from Coma in Neurointensive Care Units: Preliminary Findings from a Multicenter Qualitative Study Katherine Meurer
08:00 AM - 09:00 AM PDT	Abstract	12-010 - Ongoing Trial of Transcranial Magnetic Stimulation (TMS) for Chronic OroFacial Pain (COFP) Mallory E. Blackwood, MD
08:00 AM - 09:00 AM PDT	Abstract	12-011 - Continuous subcutaneous apomorphine infusion for the management of Parkinson’s disease at the end-of-life: two preliminary case reports Manon Auffret, PhD, PharmD
08:00 AM - 09:00 AM PDT	Abstract	6-001 - Virtual Reality Testing to Assess Cerebral Visual Impairment in X-linked Adrenoleukodystrophy Melissa Bambery, Other
08:00 AM - 09:00 AM PDT	Abstract	6-002 - Refractory Acute Disseminated Encephalomyelitis-like Illness Found to be CNS-isolated Hemophagocytic Lymphohistiocytosis due to a Novel PRF1 Mutation Cynthia X. Wang, MD
08:00 AM - 09:00 AM PDT	Abstract	6-003 - Functional MRI Correlates of Intelligence Quotient and Visual-Motor Coordination in Pediatric Multiple Sclerosis Laura Cacciaguerra, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	6-004 - Cerebral Visual Impairment in Cerebral Adrenoleukodystrophy: Prevalence, Presentation, and Neuroimaging Correlates Melissa Bambery, Other
08:00 AM - 09:00 AM PDT	Abstract	6-005 - Comparing the natural history of pediatric multiple sclerosis with onset before or after pubertal age Ermelinda De Meo
08:00 AM - 09:00 AM PDT	Abstract	7-001 - The interplay between age at menopause, insomnia, and cognitive health: a population-based study Monica Shieu, PhD
08:00 AM - 09:00 AM PDT	Abstract	7-002 - Improving Early Recognition of Mimics of Creutzfeldt-Jakob Disease in Clinical Practice Evelyn Lazar, MD
08:00 AM - 09:00 AM PDT	Abstract	7-004 - Companion Animals and Cognitive Health; A Population-Based Study Monica Shieu, PhD
08:00 AM - 09:00 AM PDT	Abstract	7-005 - Open-ended, value-based decision making requires semantic memory: a computational, imaging, and clinical study Andrew Kayser, MD, PhD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	7-006 - Clinical Profile of Frontotemporal Dementia: Case Series from a Neurological Care Center in Peru Sheila C. Suarez, MD
08:00 AM - 09:00 AM PDT	Abstract	1-001 - Psychometric Evaluation of the Idiopathic Hypersomnia Severity Scale Benjamin Banderas, Other
08:00 AM - 09:00 AM PDT	Abstract	1-002 - Content Validity of the Idiopathic Hypersomnia Severity Scale Benjamin Banderas, Other
08:00 AM - 09:00 AM PDT	Abstract	1-003 - Long-Term Effects of Lower-Sodium Oxybate on Functioning and Work Productivity in Participants With Idiopathic Hypersomnia Richard K. Bogan, MD
08:00 AM - 09:00 AM PDT	Abstract	1-004 - Long-Term Efficacy and Safety of Lower-Sodium Oxybate in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adults With Idiopathic Hypersomnia Nancy R. Foldvary-Schaefer, DO, FAAN
08:00 AM - 09:00 AM PDT	Abstract	1-005 - Timing and Duration of Adverse Events in a Clinical Trial of Lower-Sodium Oxybate in Participants With Narcolepsy With Cataplexy Richard K. Bogan, MD
08:00 AM - 09:00 AM PDT	Abstract	10-001 - Cardiac Effects of Lamotrigine in a Veteran Population Alexis Biehl
08:00 AM - 09:00 AM PDT	Abstract	10-002 - Aggregated Safety and Tolerability Experience from the Ganaxolone Development Program
08:00 AM - 09:00 AM PDT	Abstract	10-003 - Non-Seizure Related Outcomes With Real-World Use of Cannabidiol (CBD) in Lennox-Gastaut Syndrome and Dravet Syndrome: BECOME, A Caregiver Survey Anne T. Berg, PhD
08:00 AM - 09:00 AM PDT	Abstract	10-004 - Cannabidiol decreases seizure severity and brain temperature in treatment-resistant epilepsy. Ayushe A. Sharma
08:00 AM - 09:00 AM PDT	Abstract	10-005 - The Effects of Pregnancy on Levetiracetam Levels and Seizure Frequency Kruthika Shanmugam, MD
08:00 AM - 09:00 AM PDT	Abstract	10-006 - Cenobamate for Uncontrolled Focal Seizures in Patients Living in a Group Home or With a Developmental Disability Gregory S. Connor, MD
08:00 AM - 09:00 AM PDT	Abstract	4-001 - Are Elevated Interleukin-6 Serum Levels Associated with Increased Encephalopathy and In-hospital Mortality rates in SARS-CoV2 Patients Pratibha Surathi, MD
08:00 AM - 09:00 AM PDT	Abstract	4-002 - Refractory Rhombencephalitis Secondary to SARS-CoV-2 Infection: A Case Report Alexandra M. Wood, MD
08:00 AM - 09:00 AM PDT	Abstract	4-003 - A rare case of an acute ascending longitudinally extensive necrotizing transverse myelitis in a young woman: a severe post-COVID-19 infection neurological complication Franklyn Rocha Cabrero, MD
08:00 AM - 09:00 AM PDT	Abstract	4-004 - Diagnostic Characteristics and Outcomes of Chronic Meningitis Joseph Seemiller, MD
08:00 AM - 09:00 AM PDT	Abstract	4-005 - Creutzfeldt-Jacob Disease: The Long and Short of It Katherine A. Stiles, MD
08:00 AM - 09:00 AM PDT	Abstract	4-006 - A Case of Creutzfeldt-Jakob Disease Suspected to be Acquired from Gelatin Capsules Gaurav Kathuria, MD
08:00 AM - 09:00 AM PDT	Abstract	4-007 - Infectious Causes of Chronic Meningitis Tyler Crissinger, MD
08:00 AM - 09:00 AM PDT	Abstract	13-002 - A Challenging Case of Cerebral Amyloid Angiopathy-related Inflammation (CAAri): Implications for Secondary Stroke Prevention and Immunomodulation Therapies Joseph Nguyen, DO
08:00 AM - 09:00 AM PDT	Abstract	13-003 - Tremor Associated with a Frontal and Parietal Cortical Infarct Sayyeda Zahra, MD
08:00 AM - 09:00 AM PDT	Abstract	13-004 - Carotis Stenosis Presenting as Hemichorea Parisa Heidari, MD
08:00 AM - 09:00 AM PDT	Abstract	13-005 - Cortical Hemiballismus Associated With An Isolated Insular And Temporal Infarct: A Case Report Jaemyoung Sung
08:00 AM - 09:00 AM PDT	Abstract	13-006 - An unusual relapse of Amyloid-Beta related Angiitis Lamya Ibrahim, MD, MBBS
08:00 AM - 09:00 AM PDT	Abstract	13-007 - Cavernous Malformations: A Mini-Case-Series on Diagnosis and Management Khadija Awais, MBBS
08:00 AM - 09:00 AM PDT	Abstract	13-008 - Ischemic Stroke as a Rare Manifestation from Graft Versus Host Renal Failure and Immunosuppressive Therapy Mahrin Rahman, DO
08:00 AM - 09:00 AM PDT	Abstract	13-009 - An Unusual Cause of Septic Emboli Mariel Davila Martinez, MD
08:00 AM - 09:00 AM PDT	Abstract	13-010 - Severe Allergic Reaction with Cerebral Edema Post Flow-Diverter Device Placement for Cerebral Aneurysm Avi Landman, MD
08:00 AM - 09:00 AM PDT	Abstract	5-001 - Telemedicine utilization and patient satisfaction in an ambulatory movement disorders clinic during COVID-19
08:00 AM - 09:00 AM PDT	Abstract	5-002 - TeleSCOPE: A Real-World Study of Telehealth for the Detection and Treatment of Drug-Induced Movement Disorders Morgan Bron
08:00 AM - 09:00 AM PDT	Abstract	5-003 - The Impact of Telemedicine on Serious Mental Illness and Movement Disorders: A Literature Review and Gap Analysis Eric Jen
08:00 AM - 09:00 AM PDT	Abstract	5-004 - Impact of COVID-19 on Movement Disorders Patients in the Outpatient Setting Shaila Ghanekar
08:00 AM - 09:00 AM PDT	Abstract	5-005 - THRIVE-PD: Transforming Health and Resilience through Interdisciplinary Virtual Engagement in Parkinson Disease Roshini Srinivasan
08:00 AM - 09:00 AM PDT	Abstract	5-006 - The Impact of COVID-19 on People with Parkinson’s: Insights from Wearable Sensors Meghan E. Pawlik, MS
08:00 AM - 09:00 AM PDT	Abstract	5-007 - A novel tele-rehabilitation program aimed at reducing fall risk in Parkinson’s Disease patients Jessica Joyce
08:00 AM - 09:00 AM PDT	Abstract	5-008 - Clinical Characteristics of COVID-19 in Patients with Parkinson’s Disease
08:00 AM - 09:00 AM PDT	Abstract	2-001 - Factors associated with Idiopathic Intracranial Hypertension (IIH) in a population-based cohort. Parashar Koirala, MD, MBBS
08:00 AM - 09:00 AM PDT	Abstract	2-002 - Posterior Reversible Encephalopathy Syndrome (PRES) from Immune Check Point Inhibitors (ICIs) Sumayya Naz, MD
08:00 AM - 09:00 AM PDT	Abstract	2-003 - Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient with Isolated Bilateral Hippocampal Atrophy: A Case Report Tapasya Surti, DO
08:00 AM - 09:00 AM PDT	Abstract	2-004 - Case Report and Novel Theory for Transient Global Amnesia William J. Kingston, MD
08:00 AM - 09:00 AM PDT	Abstract	2-005 - A case of pembrolizumab related PRES Shreeja Kadakia, MD
08:00 AM - 09:00 AM PDT	Abstract	11-001 - 24-Week Results From Phase 3 Study MT-1186-A01 an Open-Label, Multicenter Safety Study of Oral Edaravone in Subjects With Amyotrophic Lateral Sclerosis Angela L. Genge, MD
08:00 AM - 09:00 AM PDT	Abstract	11-002 - Lessons Learned From A Large-Scale Audio-Visual Remote Data Collection For Amyotrophic Lateral Sclerosis Research Alexander Sherman
08:00 AM - 09:00 AM PDT	Abstract	11-003 - Machine Learning Enables Smaller ALS Clinical Trials Daniele Bertolini, PhD
08:00 AM - 09:00 AM PDT	Abstract	11-004 - Inhibiting C1q Improves Compound Muscle Action Potential and Reduces Neuronal Damage in the SOD1G93A Mouse Model Yaisa Andrews-zwilling
08:00 AM - 09:00 AM PDT	Abstract	11-005 - Suppression of MicroRNA-9-5p Mitigates TDP-43 Neurotoxicity in ALS Liang Lu, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	11-006 - Chlorovirus Exposure in ALS Patients Identified through Serum Antibodies also Accelerates Motor Deterioration in SOD1G93A Transgenic Mice Gary L. Pattee, MD
08:00 AM - 09:00 AM PDT	Abstract	11-007 - Filtration attenuates sporadic ALS CSF-induced motor neuron death in vitro Ivy Gao
08:00 AM - 09:00 AM PDT	Abstract	11-008 - Using In Vitro Experiments to Determine MFN2's Function in ALS Kristi Russell, PhD

Faculty Disclosures
	No disclosure on file
Julia M. Soto, MPH	Julia Soto has nothing to disclose.
Diana Ontiveros, MD	Dr. Ontiveros has nothing to disclose.
Franco Granella	Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono.
Jon Downie, PhD	Dr. Downie has nothing to disclose.
Muhammad Bilal Tariq, MBBS	Dr. Tariq has nothing to disclose.
Roberto Bergamaschi	Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Mahrin Rahman, DO	Dr. Rahman has nothing to disclose.
Amanda L. Porter, MD	Dr. Porter has nothing to disclose.
Edward J. Gettings, DO	Dr. Gettings has nothing to disclose.
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
Sneha Mantri, MD, MS	Dr. Mantri has received personal compensation in the range of $0-$499 for serving as a Consultant for Deep Brain Innovations, LLC. Dr. Mantri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grey Matter Technology. The institution of Dr. Mantri has received research support from The Michael J Fox Foundation for Parkinson Research.
Manon Auffret, PhD, PharmD	Dr. Auffret has received personal compensation for serving as an employee of France Développement Electronique. The institution of Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Britannia. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aguettant. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Auffret has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Britannia. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Auffret has received research support from Association France Parkinson. The institution of Dr. Auffret has received research support from Homeperf. The institution of Dr. Auffret has received research support from LVL. The institution of Dr. Auffret has received research support from University of Rennes. The institution of Dr. Auffret has received research support from Aguettant. The institution of Dr. Auffret has received research support from Linde. The institution of Dr. Auffret has received research support from Plateforme Nationale pour la recherche sur la fin de vie. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care.
Mariel Davila Martinez, MD	Dr. Davila Martinez has nothing to disclose.
Ted Yednock, PhD	Ted Yednock, PhD has received personal compensation for serving as an employee of Annexon Inc. Ted Yednock, PhD has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Annexon Inc. Ted Yednock, PhD has received stock or an ownership interest from Annexon Inc. Ted Yednock, PhD has received intellectual property interests from a discovery or technology relating to health care.
Laurent Tatu, MD	No disclosure on file
Valentina Torri Clerici	Valentina Torri Clerici has nothing to disclose.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Marc Weisskopf, PhD	Dr. Weisskopf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Weisskopf has received research support from Biogen. The institution of Dr. Weisskopf has received research support from NIH.
Leila Saadatpour, MD	Dr. Saadatpour has nothing to disclose.
Mark Witcher	No disclosure on file
Parul Agarwal	No disclosure on file
Isabel Victoria Narvaez- Correa, MD	Dr. Narvaez- Correa has nothing to disclose.
Paisith Piriyawat, MD	Dr. Piriyawat has nothing to disclose.
Ali M. Mendelson, MD	Dr. Mendelson has nothing to disclose.
Mehmood Rashid, MD	Dr. Rashid has nothing to disclose.
Tracy Dixon-Salazar, PhD	Dr. Dixon-Salazar has received personal compensation for serving as an employee of Lennox-Gastaut Syndrome (LGS) Foundation. Dr. Dixon-Salazar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuelis.
Jamie LaBuzetta, MD	Dr. LaBuzetta has nothing to disclose.
Marta Simone	Marta Simone, 11772 has nothing to disclose.
Nancy R. Foldvary-Schaefer, DO, FAAN	Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Francesco Patti, MD	Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla.
Sayyeda Zahra, MD	Dr. Zahra has nothing to disclose.
Ann N. Ly, MD	Dr. Ly has nothing to disclose.
Kendra Martello	No disclosure on file
Susanne Muehlschlegel, MD, MPH, FAAN	Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma Inc.. Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Claire Manley	No disclosure on file
Kyle T. Mitchell, MD	Dr. Mitchell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Mitchell has received research support from Medtronic. The institution of Dr. Mitchell has received research support from Deep Brain Innovations. The institution of Dr. Mitchell has received research support from National Institutes of Health. The institution of Dr. Mitchell has received research support from National Institute on Aging.
Daniel Krashin, MD	Dr. Krashin has nothing to disclose.
Danielle Larson, MD	Dr. Larson has received personal compensation in the range of $0-$499 for serving as a Consultant for Acadia Pharmaceuticals.
Ilaria Pesci	No disclosure on file
Evelyn Lazar, MD	Dr. Lazar has nothing to disclose.
Hongyan Wu, NP	Mrs. Wu has nothing to disclose.
Ferdinand Schweser, PhD	Dr. Schweser has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Sean Gratton, MD	Dr. Gratton has nothing to disclose.
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE.
Marc Verin	Mr. Verin has nothing to disclose.
Tigran Kesayan, MD	Dr. Kesayan has nothing to disclose.
M Bakri Hammami, MD	Dr. Hammami has received intellectual property interests from a discovery or technology relating to health care.
Kristi Russell, PhD	The institution of Mrs. Russell has received research support from Margolis Foundation.
Stewart J. Tepper, MD	Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cleaview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Medical Comm. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Education Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' Education Resource. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical Education. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview.
Tiffany Braley, MD	Dr. Braley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluestar BioAdvisors. The institution of Dr. Braley has received research support from NIH. The institution of Dr. Braley has received research support from PCORI. The institution of Dr. Braley has received research support from National Multiple Sclerosis Society.
Ashok Verma, MD, FAAN	Dr. Verma has nothing to disclose.
Florian Eichler, MD	An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for SwanBio Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Eichler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Origin Biosciences. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orchard Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobahn Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluebird Bio. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. Dr. Eichler has received stock or an ownership interest from SwanBio Therapeutics. The institution of Dr. Eichler has received research support from Bluebird Bio. The institution of Dr. Eichler has received research support from Minoryx Therpeutics. The institution of Dr. Eichler has received research support from Sio Therapeutics. Dr. Eichler has received intellectual property interests from a discovery or technology relating to health care.
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Eric Lancaster, MD, PhD	Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program.
James D. Berry, MD MPH	Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene Nanomedicine. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma Holdings of America. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Berry has stock in ReactNeuro. The institution of Dr. Berry has received research support from Biogen. The institution of Dr. Berry has received research support from MT Pharma of America. The institution of Dr. Berry has received research support from Rapa Therapeutics. The institution of Dr. Berry has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Berry has received research support from Alexion. The institution of Dr. Berry has received research support from nQ Medical. The institution of Dr. Berry has received research support from ALSA. The institution of Dr. Berry has received research support from MDA. The institution of Dr. Berry has received research support from Amylyx. The institution of Dr. Berry has received research support from Transposon. Dr. Berry has a non-compensated relationship as a Scientific Advisor with Everything ALS that is relevant to AAN interests or activities.
Yan Zhang	No disclosure on file
Franklyn Rocha Cabrero, MD	Dr. Rocha Cabrero has nothing to disclose.
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Sidra Saleem, MD	Dr. Saleem has nothing to disclose.
Sumayya Naz, MD	Dr. Naz has nothing to disclose.
Jeffrey M. Kornitzer, MD	Dr. Kornitzer has nothing to disclose.
Daniel Selness	Mr. Selness has received personal compensation for serving as an employee of Mitsubishi Tanabe.
Mitra Afshari, MD	The institution of Dr. Afshari has received research support from Consolidated Anti-Aging Foundation, Chicago, IL. The institution of Dr. Afshari has received research support from Rush University Department of Neurology.
Maria Trojano	Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Grant W. Zeigler, DO	Dr. Zeigler has nothing to disclose.
Camille S. Corre, MD	Dr. Corre has nothing to disclose.
Joel M. Trugman, MD, FAAN	Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Daniel C. Kelly	Mr. Kelly has nothing to disclose.
Andrea Hernandez	Ms. Hernandez has nothing to disclose.
Chelsea Kaplan	No disclosure on file
Noel Cabanas	No disclosure on file
Stella Jensen-Roberts	Ms. Jensen-Roberts has nothing to disclose.
Matthew N. Jaffa, DO	Dr. Jaffa has nothing to disclose.
John Herbst, DO	Dr. Herbst has nothing to disclose.
Winston Chiong, MD	The institution of Dr. Chiong has received research support from the National Institutes of Health. The institution of Dr. Chiong has received research support from the Dana Foundation. Dr. Chiong has received personal compensation in the range of $500-$4,999 for serving as a member, NeuroEthics Working Group with National Institutes of Health.
Morgan Bron	Morgan Bron has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.. Morgan Bron has stock in Neurocrine.
Kelly Baldwin, MD	Dr. Baldwin has nothing to disclose.
Elissa Wilker, Other	Dr. Wilker has received personal compensation for serving as an employee of Alexion. Dr. Wilker has received personal compensation for serving as an employee of Sanofi Genzyme. An immediate family member of Dr. Wilker has received personal compensation for serving as an employee of Biogen. An immediate family member of Dr. Wilker has received personal compensation for serving as an employee of Perkin Elmer. Dr. Wilker has stock in Alexion. Dr. Wilker has received research support from NIH.
Saqib A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Patricia A. Weisner, MD, PhD	Dr. Weisner has nothing to disclose.
Jonathan R. Galli, MD	Dr. Galli has nothing to disclose.
Mohona Reza, MD	Dr. Reza has nothing to disclose.
David Dunigan	No disclosure on file
Breana Taylor, MD	Dr. Taylor has nothing to disclose.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Filterlex. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for 3D Communications. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Live. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Ye Su, DO	Dr. Su has nothing to disclose.
Ankur Garg, MD	Dr. Garg has nothing to disclose.
Luis Guada-Delgado, MD	Dr. Guada-Delgado has nothing to disclose.
Fahad Salman	No disclosure on file
Gregory S. Connor, MD	The institution of Dr. Connor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK Life Sciences. The institution of Dr. Connor has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences.
MerryJean Losso, MD	Dr. Losso has nothing to disclose.
Giacomo Lus	Giacomo Lus has nothing to disclose.
Nathan Goldstein	No disclosure on file
John Furey	Mr. Furey has nothing to disclose.
Antonio Bertolotto, MD, FAAN	Dr. Bertolotto has nothing to disclose.
Mercedes P. Jacobson, MD	The institution of Dr. Jacobson has received research support from Engage. The institution of Dr. Jacobson has received research support from XENON. The institution of Dr. Jacobson has received research support from SK Life Sciences.
James P. Ho, MD	Dr. Ho has nothing to disclose.
Marco Rovaris	No disclosure on file
Shaila Ghanekar	Miss Ghanekar has nothing to disclose.
Harald Murck, MD, PhD	Dr. Murck has received personal compensation for serving as an employee of Aptinyx. Dr. Murck has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aptinyx/Digestome/Karuna. Dr. Murck has stock in Aptinyx. Dr. Murck has received intellectual property interests from a discovery or technology relating to health care.
Patricia Chandler	No disclosure on file
Amanda M. Nagy, MD	Dr. Nagy has nothing to disclose.
Jennifer W. McVige, MD	Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. The institution of Dr. McVige has received research support from Amgen. The institution of Dr. McVige has received research support from Eli Lily. The institution of Dr. McVige has received research support from Biohaven. The institution of Dr. McVige has received research support from Lundbeck. The institution of Dr. McVige has received research support from Dent Family Foundation. Dr. McVige has a non-compensated relationship as a Neurology Board with UCNS that is relevant to AAN interests or activities. Dr. McVige has a non-compensated relationship as a Board Exam Board Member with ABPN that is relevant to AAN interests or activities.
Julieta E. Arena, MD	Dr. Arena has nothing to disclose.
Sheila C. Suarez, MD	The institution of Dr. Suarez has received research support from Alzheimer's Association.
Alexa Beiser	No disclosure on file
Cleo Zarina A. Reyes, MD	Dr. Reyes has nothing to disclose.
Kerstin Bettermann, MD, PhD, FANA, FAAN	Dr. Bettermann has nothing to disclose.
Lucas Alessandro, Sr., MD	Dr. Alessandro has nothing to disclose.
Natalia Murinova, MD, FAAN	Dr. Murinova has nothing to disclose.
Danish Kherani, MD	Dr. Kherani has nothing to disclose.
Cynthia Gonzalez, MD	Dr. Gonzalez has nothing to disclose.
Paola Cavalla	No disclosure on file
Tyler Crissinger, MD	Dr. Crissinger has nothing to disclose.
John Ko	Mr. Ko has nothing to disclose.
Anastasie M. Dunn-Pirio, MD	Dr. Dunn-Pirio has nothing to disclose.
Alessandra Lugaresi, MD	Dr. Lugaresi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharma. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Sqibb. Dr. Lugaresi has a non-compensated relationship as a Speaker at meetings, participant in trials with Fondazione Italiana Sclerosi Multipla that is relevant to AAN interests or activities.
Khadija Awais, MBBS	Dr. Awais has nothing to disclose.
Gary L. Pattee, MD	The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals.
Rony Dekermenjian, MD	Dr. Dekermenjian has nothing to disclose.
Rachelle Hornick	No disclosure on file
Jonathan Donnelly, MB BCh BaO	Dr. Donnelly has nothing to disclose.
Christian C. Prusinski, DO	Dr. Prusinski has nothing to disclose.
Alfonso S. Lopez, MD	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech .
Mark B. Bromberg, MD, PhD, FAAN	Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT Pharma. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Medical reviewer with Department of Justice, Vaccination Compensation Board.
Uwe Reuter	Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Liily Deutschland. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Uwe Reuter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape . Uwe Reuter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for StreaMEdUp. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Reuter has received research support from Novartis.
Roman Skowronski, MD, PhD	Dr. Skowronski has nothing to disclose.
Shreeja Kadakia, MD	Dr. Kadakia has nothing to disclose.
Claire Creutzfeldt, MD	The institution of Dr. Creutzfeldt has received research support from NINDS. The institution of Dr. Creutzfeldt has received research support from NINR.
Avi Landman, MD	Dr. Landman has nothing to disclose.
Barbara G. Vickrey, MD, MPH, FAAN	The institution of Dr. Vickrey has received research support from NIH. Dr. Vickrey has received personal compensation in the range of $0-$499 for serving as a Grant reviewer, committee co-chair with NIH. Dr. Vickrey has received personal compensation in the range of $0-$499 for serving as a conference advisory committee with University of Rochester. Dr. Vickrey has a non-compensated relationship as a Second Vice President with Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Vickrey has a non-compensated relationship as a Nominating Committee member of Stroke Council with American Heart Association that is relevant to AAN interests or activities. Dr. Vickrey has a non-compensated relationship as a Nominating Committee Chair with American Neurological Association that is relevant to AAN interests or activities.
Susan Hutchinson	Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Yaisa Andrews-zwilling	No disclosure on file
Kruthika Shanmugam, MD	Dr. Shanmugam has nothing to disclose.
Gen Sobue, MD	Dr. Sobue has nothing to disclose.
Rizamarie Empeno, MD	Dr. Empeno has nothing to disclose.
Jordan Weiss	No disclosure on file
Craig A. Williamson, MD	The institution of Dr. Williamson has received research support from Xoran Technolies, LLC. The institution of Dr. Williamson has received research support from United States Department of Defense. Dr. Williamson has received intellectual property interests from a discovery or technology relating to health care.
Liang Lu, MD, FAAN	Dr. Lu has nothing to disclose.
Nicole A. Lessard, RN	Ms. Yarab has nothing to disclose.
Nathalie Jette, MD, MSc, FRCPC, FAAN	Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Raquel Norel	Raquel Norel has received personal compensation for serving as an employee of IBM. Raquel Norel has received intellectual property interests from a discovery or technology relating to health care.
Alejandro Salah, MD, PhD, MBA, MHA	Dr. Salah has nothing to disclose.
Dong Jin Shin, MD	Dr. Shin has nothing to disclose.
Mark Girgis, DO	Dr. Girgis has nothing to disclose.
Christopher Tarolli, MD	Dr. Tarolli has received personal compensation for serving as an employee of University of Rochester. The institution of Dr. Tarolli has received research support from Biosensics. The institution of Dr. Tarolli has received research support from National Institutes of Health. The institution of Dr. Tarolli has received research support from Biogen. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Speaker, Committee Member with American Academy of Neurology. Dr. Tarolli has a non-compensated relationship as a Committee Member with American Academy of Neurology that is relevant to AAN interests or activities.
Jamie Wong, PhD	Dr. Wong has nothing to disclose.
Ahmed Z. Obeidat, MD, PhD	Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities.
Cynthia X. Wang, MD	Dr. Wang has nothing to disclose.
Peggy Auinger	Ms. Auinger has nothing to disclose.
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Paola Valsasina	No disclosure on file
Lama Al-Khoury, MD	Dr. Al-Khoury has nothing to disclose.
Temenuzhka G. Mihaylova, MD, PhD	Dr. Mihaylova has nothing to disclose.
Omer W. Naveed, MD	Dr. Naveed has nothing to disclose.
Gaurav Kathuria, MD	Dr. Kathuria has nothing to disclose.
Atef Kokash, DO	Dr. Kokash has nothing to disclose.
Steven R. Dunham, Jr., MD	Dr. Dunham has nothing to disclose.
Muhammad-Atif Zubairi, MD	Dr. Zubairi has nothing to disclose.
Summer Gibson, MD	An immediate family member of Dr. Gibson has received personal compensation for serving as an employee of Recursion Pharmaceuticals. Dr. Gibson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. An immediate family member of Dr. Gibson has received stock or an ownership interest from Recursion Pharmaceuticals . An immediate family member of Dr. Gibson has received intellectual property interests from a discovery or technology relating to health care. Dr. Gibson has received publishing royalties from a publication relating to health care.
Eric Jen	Eric Jen has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Ermelinda De Meo	Ms. De Meo has nothing to disclose.
Andrew M. Blumenfeld, MD, FAAN	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck.
Ashley Streseman, MD	Dr. Streseman has nothing to disclose.
Philippe Couratier, PhD	Dr. Couratier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Couratier has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Couratier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier .
Katherine A. Stiles, MD	Dr. Stiles has nothing to disclose.
Bridget Bagert, MD, MPH	Dr. Bagert has nothing to disclose.
Yves Dauvilliers, MD, PhD	Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel.
Jorge L. Morales, MD	Dr. Morales has nothing to disclose.
E. Ray Dorsey, MD, MBA	Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainNeuroBio. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Clintrex. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali Therapeutics. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Grand Rounds. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medopad. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Michael J. Fox Foundation. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Origent Data Sciences, Inc.. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Otsuka. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion Pharma. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Alzheimer's Drug Discovery Foundation. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial-Biotech Investments, Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BluePrint Orphan, Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Caraway T. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DeciBio. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NACCME/CONSULTANT 360. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Olson Research Group. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pear Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caraway. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Huntington Study Group. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCM Education. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician's Education Resource, LLC. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Karger. Dr. Dorsey has stock in Grand Rounds. The institution of Dr. Dorsey has received research support from Biogen - WATCH-PD. The institution of Dr. Dorsey has received research support from NIH - AHPD. Dr. Dorsey has received research support from NIH - Biosensics. The institution of Dr. Dorsey has received research support from Pfizer - SQUAD. The institution of Dr. Dorsey has received research support from Greater Rochester Health Foundation - PDCNY. The institution of Dr. Dorsey has received research support from Safra Foundation - PDCNY. The institution of Dr. Dorsey has received research support from Burroughs Wellcome - Smartphones. The institution of Dr. Dorsey has received research support from NIH - CTSA. The institution of Dr. Dorsey has received research support from Gary & Mary West Foundation - d.health. The institution of Dr. Dorsey has received research support from PCORI -PD Virtual Care. The institution of Dr. Dorsey has received research support from WAVE Life Sciences. The institution of Dr. Dorsey has received research support from Acadia Pharmaceuticals - PDTV. The institution of Dr. Dorsey has received research support from Roche Pharmaceuticals - PDTV. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from PCORI. The institution of Dr. Dorsey has received research support from Safra Foundation.
Michelle Finnegan	Michelle Finnegan has received personal compensation for serving as an employee of AbbVie.
Xiaoping Ning	Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical . Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical.
Vincenzo Brescia Morra, MD	Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Jesse Menville	Ms. Menville has nothing to disclose.
Natalia Gonzalez Caldito, MD	Dr. Gonzalez Caldito has nothing to disclose.
Yarema Bezchlibnyk	No disclosure on file
Nitin Goyal, MD	No disclosure on file
Mallory E. Blackwood, MD	Ms. Blackwood has nothing to disclose.
Nadia M. Celestin, BS	Miss Celestin has nothing to disclose.
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Isabelle Arnulf, MD	Dr. Arnulf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharma. Dr. Arnulf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE pharma. Dr. Arnulf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IDORSIA Pharma. Dr. Arnulf has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB Pharma. The institution of Dr. Arnulf has received research support from BIOPROJET pharma. The institution of Dr. Arnulf has received research support from VITALAIRE. The institution of Dr. Arnulf has received research support from French SLEEP Socity (SFRMS). The institution of Dr. Arnulf has received research support from Paris Brain Insitute. Dr. Arnulf has a non-compensated relationship as a scientific advisory with Jazz Pharma that is relevant to AAN interests or activities. Dr. Arnulf has a non-compensated relationship as a scientific advisory with Theranexus that is relevant to AAN interests or activities.
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Aria Anvar	Aria Anvar has nothing to disclose.
Ivy Gao	Miss Gao has nothing to disclose.
Erafat Rehim, MD	Dr. Rehim has nothing to disclose.
Melissa Motta, MD, MPH	Dr. Motta has nothing to disclose.
Jonathan Walsh, PhD	Dr. Walsh has received personal compensation for serving as an employee of Unlearn.AI. Dr. Walsh has received intellectual property interests from a discovery or technology relating to health care.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Ngoc Minh D. Le, MD	Dr. Le has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Le has stock in Greenwich Biosciences.
Ayushe A. Sharma	Mrs. Sharma has nothing to disclose.
Yoji Hoshina, MD	Dr. Hoshina has nothing to disclose.
Mary E. Jenkins, MD	Dr. Jenkins has nothing to disclose.
Andrew Kayser, MD, PhD, FAAN	Dr. Kayser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. The institution of Dr. Kayser has received research support from NIH. The institution of Dr. Kayser has received research support from VA RR&D.
William J. Kingston, MD	Dr. Kingston has nothing to disclose.
Brian J. Hanrahan, MD	Dr. Hanrahan has received personal compensation for serving as an employee of Nowyouknow Neuro.
Melissa Bambery, Other	Ms. Bambery has nothing to disclose.
Roshini Srinivasan	Mrs. Srinivasan has nothing to disclose.
Han-Cheon Kim	No disclosure on file
Jennifer H. Yang, MD	Dr. Yang has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Yang has received research support from Pediatric Epilepsy Research Foundation. The institution of Dr. Yang has received research support from UCB.
Peter Goadsby, MD, PhD, FRS	Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli-Lilly. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurene. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon Biopharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. The institution of Dr. Goadsby has received research support from Kallyope. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Executive roles with American Headache Society that is relevant to AAN interests or activities.
Alberto Maud, MD	Dr. Maud has nothing to disclose.
Jed Black, MD	Jed Black, MD has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Jed Black, MD has stock in Jazz Pharmaceuticals. Jed Black, MD has stock in .
Katherine Meurer	Katherine Meurer has nothing to disclose.
Toluwalase O. Tofade, MBBS	Dr. Tofade has nothing to disclose.
Byung-kun Kim, MD	Dr. Kim has nothing to disclose.
Eleonora Cocco	No disclosure on file
Sherry Danese	No disclosure on file
Anne T. Berg, PhD	Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded. Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biomarin. The institution of Dr. Berg has received research support from FamilieSCN2A Foundation.
Nizar Souayah, MD, FAAN	Dr. Souayah has received publishing royalties from a publication relating to health care.
Pratibha Surathi, MD	Dr. Surathi has nothing to disclose.
Nikhil Dhuna, MD	Dr. Dhuna has nothing to disclose.
Harini Sarva, MD, FAAN	Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Covance. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB.
Rimal Bera	No disclosure on file
Pinky Agarwal, MD, FAAN	Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenx Bio . Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharma. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. An immediate family member of Dr. Agarwal has stock in ACTINIUM PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Aquestive Therapeutics. An immediate family member of Dr. Agarwal has stock in Corcept Therapeutics. An immediate family member of Dr. Agarwal has stock in Catalyst Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in Gevo Inc. An immediate family member of Dr. Agarwal has stock in G1 Therapeutics. An immediate family member of Dr. Agarwal has stock in Marinus Pharnmaceuticals. An immediate family member of Dr. Agarwal has stock in OVID Therapeutics. An immediate family member of Dr. Agarwal has stock in Pieris Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in ASSERTIO HOLDINGS INC . An immediate family member of Dr. Agarwal has stock in BLUEBIRD BIO INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in GALECTO INC . An immediate family member of Dr. Agarwal has stock in GLYCOMIMETICS INC. An immediate family member of Dr. Agarwal has stock in Zevra Therapeutics. An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in MEREO BIOPHARMA GROUP PLC. An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in PHASEBIO PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in PROTALIX BIOTHERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in Puma Biotech. An immediate family member of Dr. Agarwal has stock in Xeris Biopharma. An immediate family member of Dr. Agarwal has stock in Tonix Pharma. An immediate family member of Dr. Agarwal has stock in Spruce Biosciences. An immediate family member of Dr. Agarwal has stock in Cassava Sciences. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Cue Biopharma. An immediate family member of Dr. Agarwal has stock in Caribou Biosciences. An immediate family member of Dr. Agarwal has stock in Capricor Therapeutics. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Passage Bio. An immediate family member of Dr. Agarwal has stock in Sutro Biopharma. An immediate family member of Dr. Agarwal has stock in Karyopharma. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Oncolytic Biotech. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vistagen Therapeutics. An immediate family member of Dr. Agarwal has stock in Tscan Therapeutics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Sun Pharma. The institution of Dr. Agarwal has received research support from Inhibikase.
Grant Meeks, MD	Mr. Meeks has nothing to disclose.
Paul H. Janda, DO, JD, FAAN	Dr. Janda has nothing to disclose.
Richard K. Bogan, MD	Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Philips. The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Fresca. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care. Dr. Bogan has a non-compensated relationship as a Chair with National Sleep Foundation that is relevant to AAN interests or activities.
Benjamin Banderas, Other	Mr. Banderas has nothing to disclose.
Joseph Seemiller, MD	Dr. Seemiller has nothing to disclose.
Irina Agarkova	No disclosure on file
Susmit Tripathi, MD	Dr. Tripathi has nothing to disclose.
Umberto Aguglia, MD	Dr. Aguglia has nothing to disclose.
Benzi Kluger, MD, FAAN	The institution of Dr. Kluger has received research support from NIH. The institution of Dr. Kluger has received research support from PCORI.
Anantha Vellipuram, MD	Dr. Vellipuram has nothing to disclose.
David W. Dodick, MD, FAAN	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Ian Miller, MD	Dr. Miller has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Miller has stock in Marinus Pharmaceuticals.
Sudha Seshadri, MD, FAAN	Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Elizabeth Finger, MD, FAAN	Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali Therapeutics. The institution of Dr. Finger has received research support from CIHR. The institution of Dr. Finger has received research support from Physician Servcices Incorporated. The institution of Dr. Finger has received research support from Weston Foundation. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Annual Meeting Course Director with American Academy of Neurology.
Bhavini Srivastava, Other	Ms. Srivastava has nothing to disclose.
J. David Avila, MD	Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Hongxuyang Yu, MD	Dr. Yu has nothing to disclose.
Robin Bessemer, MD	Dr. Bessemer has nothing to disclose.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Micaela Hernandez, MD	Dr. Hernandez has nothing to disclose.
Corey R. Fehnel, MD, FAAN	Dr. Fehnel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XRHealth. The institution of Dr. Fehnel has received research support from National Institute on Aging .
Tapasya Surti, DO	Miss Surti has nothing to disclose.
Tsneem Mbydeen, MBBS	Dr. Mbydeen has nothing to disclose.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Ruth Schneider, MD, FAAN	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Escape Bio. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Acadia Pharmaceuticals. The institution of Dr. Schneider has received research support from CHDI. The institution of Dr. Schneider has received research support from Biohaven Pharmaceuticals. The institution of Dr. Schneider has received research support from Parkinson Study Group. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Telemedicine Evaluator with Parkinson's Foundation.
Sam Hooshmand, DO	Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech/Roche. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Yaakov Stern, PhD	Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Carmen Vizzino	No disclosure on file
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOMEDIA.
Patrick Eugeni	Mr. Eugeni has nothing to disclose.
Teneille Gofton, MD	The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Jamie L. Adams, MD	Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Adams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. The institution of Dr. Adams has received research support from NIH/NINDS. The institution of Dr. Adams has received research support from Biogen. The institution of Dr. Adams has received research support from The Michael J. Fox Foundation. The institution of Dr. Adams has received research support from Critical Path Institute. Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a KINECT-HD Steering Committee Member with Huntington Study Group. Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a ORCHESTRA-PD Steering Committee Member with Parkinson Study Group.
Alicia S. Parker, MD	An immediate family member of Dr. Parker has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sanara Med Tech. An immediate family member of Dr. Parker has stock in Sanara Med Tech. An immediate family member of Dr. Parker has stock in Rochal Industries. An immediate family member of Dr. Parker has stock in Rochal Parnters. The institution of Dr. Parker has received research support from Texas Alzheimer's Research and Care Consortium. The institution of an immediate family member of Dr. Parker has received research support from Rochal Industries. An immediate family member of Dr. Parker has received intellectual property interests from a discovery or technology relating to health care.
Michael J. Thorpy, MD	Dr. Thorpy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Thorpy has received publishing royalties from a publication relating to health care.
Mohammad Ghatali, MD	Dr. Ghatali has nothing to disclose.
David Y. Hwang, MD, FAAN	Dr. Hwang has received publishing royalties from a publication relating to health care. Dr. Hwang has a non-compensated relationship as a Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
M. S. Perry, MD	Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for stoke therapeutics. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded Therapeutics. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Biosciences. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Zogenix. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW Biosciences.
Catherine R. Craven, MD	Dr. Craven has nothing to disclose.
Ismael Calandri, MD	Dr. Calandri has nothing to disclose.
Emilio Portaccio	Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Emilio Portaccio has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Takeshi Sakata	Takeshi Sakata has received personal compensation for serving as an employee of Mitsubishi Tanabe.
Megan Dini, MA	Mrs. Dini has received personal compensation for serving as an employee of Parkinson's Foundation .
Adena Shahinian, DO	Dr. Shahinian has nothing to disclose.
Parisa Heidari, MD	Dr. Heidari has nothing to disclose.
Galit L. Dunietz	No disclosure on file
Robert Kotloski, MD	The institution of Dr. Kotloski has received research support from Department of Veterans Affairs.
Tom Petro	No disclosure on file
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Marco Onofrj, MD	Dr. Onofrj has nothing to disclose.
Andrew Schrepf	No disclosure on file
Qiang Zhang	Mrs. Zhang has nothing to disclose.
Seung Y. Kim, MD	Dr. Kim has nothing to disclose.
Hua Guo, PhD	Hua Guo has received personal compensation for serving as an employee of AbbVie. Hua Guo has received stock or an ownership interest from AbbVie.
Daniele Bertolini, PhD	Dr. Bertolini has received personal compensation for serving as an employee of Unlearn.AI, Inc. Dr. Bertolini has received personal compensation for serving as an employee of Quid, Inc.
Derek J. Notch, MD	Dr. Notch has nothing to disclose.
Stefan M. Pulst, MD, FAAN	Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Sviatoslav Redko, MD	Dr. Redko has nothing to disclose.
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Richard Harris	No disclosure on file
Balaji Krishnaiah, MD, FAAN	Dr. Krishnaiah has received publishing royalties from a publication relating to health care.
Marika Vianello	No disclosure on file
Dejan Jakimovski, MD, PhD	Dr. Jakimovski has nothing to disclose.
Vinutha Ganapathy, MD, MS	Dr. Ganapathy has nothing to disclose.
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Jessica Ailani, MD, FAAN	Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gore. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eneura. Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Report. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. The institution of Dr. Ailani has received research support from Satsuma. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Medical Advisor with SELF.
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Jack Reeves	Mr. Reeves has nothing to disclose.
Theresa A. Zesiewicz, MD	Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Chetan Saini, MD	Dr. Saini has nothing to disclose.
Monica Shieu, PhD	Dr. Shieu has nothing to disclose.
Eunice H. Bae, MD	Dr. Bae has nothing to disclose.
Meenakshi Bhattacharjee	No disclosure on file
Yevgeniy Isayev, MD	Dr. Isayev has nothing to disclose.
Saima Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Dena Williams, DO	Dr. Williams has nothing to disclose.
Jonathan Doan, MD	Mr. Doan has nothing to disclose.
Evan Huff, MD	Mr. Huff has nothing to disclose.
Junji Lin, PhD	Ms. Lin has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Ms. Lin has stock in Jazz Pharmaceuticals.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Global Kinetics Consulting (GKC). Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDerm. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion Neurostim LLC. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar Inc.. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus Pharma. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inhibikase. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pharma 2 B. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivifi Biotech. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ovid Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AgeX Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanex. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MDCE Suzhou. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PDNeurotechnology. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regenxbio. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tremor Research Support Group. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tris Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ameal . Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sunovion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Cerevel. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Inhibikase. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has stock in Inhibikase. Dr. Hauser has stock in Axial Therapeutics. Dr. Hauser has stock in Enterin. Dr. Hauser has stock in Revance Therapeutics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Artizan Biosciences. The institution of Dr. Hauser has received research support from Parkinsons & Movement Disorder Alliance. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Aeon Biopharma. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Bukwang Pharmaceutical Co., Ltd.. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Cynapsus Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Impax Labratories. The institution of Dr. Hauser has received research support from Integrative Research Labratories Sweden. The institution of Dr. Hauser has received research support from Lundbeck, Inc.. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuraly Inc.. The institution of Dr. Hauser has received research support from Neurocrine Biosciences. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Pharma Two B Ltd.. The institution of Dr. Hauser has received research support from Revance Therapeutics. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Sanofi Pharmaceuticals. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from SunPharma. The institution of Dr. Hauser has received research support from UCB BioPharma. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Parashar Koirala, MD, MBBS	Dr. Koirala has nothing to disclose.
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
Karla P. Figueroa	Ms. Figueroa has nothing to disclose.
James Van Etten	No disclosure on file
Jayandra Himali	No disclosure on file
Karlo J. Lizarraga, MD, MS, FAAN	Dr. Lizarraga has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for FHC. The institution of Dr. Lizarraga has received research support from Acadia. The institution of Dr. Lizarraga has received research support from Roche. The institution of Dr. Lizarraga has received research support from NIH/NINDS. The institution of Dr. Lizarraga has received research support from Takeda. Dr. Lizarraga has received personal compensation in the range of $0-$499 for serving as a Speaker with AAN Institute. Dr. Lizarraga has a non-compensated relationship as a Editorial Board Member with AAN (Brain & Life en Español) that is relevant to AAN interests or activities.
Chloe E. Hill, MD	The institution of Dr. Hill has received research support from NIH. The institution of Dr. Hill has received research support from AAN. The institution of Dr. Hill has received research support from NIH. Dr. Hill has a non-compensated relationship as a member of AAN Health Services Research Subcommittee with AAN that is relevant to AAN interests or activities.
Alina Shub, PA	The institution of Ms. Shub has received research support from Abbott and Boston Scientific .
Erik A. Guevara-Silva, MD	Dr. Guevara-Silva has nothing to disclose.
Barry E. Gidal, PhD	Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai . Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK life sciences . Dr. Gidal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK life science .
Maria P. Amato, PhD	Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Sonya T. Gleicher, MD	Dr. Gleicher has nothing to disclose.
Messoud Ashina, MD, PhD	Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Christian A. Sam, MD	Dr. Sam has nothing to disclose.
Meghan E. Pawlik, MS	Miss Pawlik has nothing to disclose.
Sean T. Kenniff, MD	Dr. Kenniff has nothing to disclose.
Alexis Biehl	Miss Biehl has nothing to disclose.
Rose P. Griffin	Ms. Griffin has nothing to disclose.
Lamya Ibrahim, MD, MBBS	Dr. Ibrahim has nothing to disclose.
Pavla Cermakova	No disclosure on file
Aaron Shoskes, DO	Dr. Shoskes has nothing to disclose.
Imran I. Ali, MD, FAAN	Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Rachna Malani, MD	Dr. Malani has nothing to disclose.
Patrizia Sola	Patrizia Sola has nothing to disclose.
Davide Maimone, MD, PhD	Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva.
Jaemyoung Sung	Mr. Sung has nothing to disclose.
Stephen Apple	Stephen Apple has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc.
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Katrin Wolfova, MD, PhD	Dr. Wolfova has received research support from Fulbright Commision.
Alexander Sherman	The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Giuseppe Salemi, MD	No disclosure on file
Larry Charleston IV, MD, MSc, FAHS	Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven Biopharmaceuticals. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member at Large with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities.
Prajwal Hegde	Mr. Hegde has nothing to disclose.
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Alexandra M. Wood, MD	Dr. Wood has nothing to disclose.
Saud A. Sadiq, MD, MB, FAAN	Dr. Sadiq has nothing to disclose.
Joshua M. Cohen, MD	No disclosure on file
Anne M. Moss, MD	No disclosure on file
Joseph Hulihan, Jr., MD	Dr. Hulihan has received personal compensation for serving as an employee of MARINUS PHARMACEUTICALS. Dr. Hulihan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ZYNERBA PHARMACEUTICALS.
Mohammad Rauf A. Chaudhry, MD, MBBS	Dr. Chaudhry has nothing to disclose.
Mario R. Cornejo Olivas, MD	The institution of Dr. Cornejo Olivas has received research support from CONCYTEC-PROCIENCIA PERU. Dr. Cornejo Olivas has a non-compensated relationship as a Board member at Rare Disorders Burou (CCI-MINSA) with Ministry of Health in Peru that is relevant to AAN interests or activities.
Joseph Nguyen, DO	Dr. Nguyen has nothing to disclose.
Brett Dabruzzo, PharmD	Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Jennie W. Taylor, MD	Dr. Taylor has received personal compensation for serving as an employee of Servier. The institution of Dr. Taylor has received research support from BMS. The institution of Dr. Taylor has received research support from Servier. The institution of Dr. Taylor has received research support from Navio. Dr. Taylor has received research support from University of Colorado. Dr. Taylor has received research support from Mt Sinai University . Dr. Taylor has received publishing royalties from a publication relating to health care.
Amarylis Velez-Perez	Amarylis Velez-Perez has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Caroline Crooms, MD, MPH	Dr. Crooms has nothing to disclose.
Jacqueline Shanley, CRC	Miss Shanley has nothing to disclose.
Jessica Joyce	Ms. Joyce has nothing to disclose.